SAMBA tool from 🧬Yubin🧬 & YunNancyHuang_lab@TAMU | New research repurposes ancient remedy for blood cancer treatment vitalrecord.tamu.edu/new-research-r…

Repurposing aspirin’s active ingredient for blood cancer treatment: Texas A&M Health researchers developed SAMBA—a salicylic acid switch that improves safety and control in CAR T-cell therapy for leukemia and lymphoma: tx.ag/SAMBA

Regents with the Texas A&M System have approved another two-year freeze on tuition and academic fees for Texas resident undergraduates at every Texas A&M System university. Texas A&M University has not raised tuition since 2021, and tuition will be frozen for the 2025–26 and 2026–27

PhoBIT tools from @zhoulaboratory | Compact genetic light switches transform disease control vitalrecord.tamu.edu/compact-geneti…

Imagine flipping a light switch to control disease inside a cell. Texas A&M Health researchers are making it possible with new genetic tools called PhoBITs. Learn more: tx.ag/PhoBITs

🧬Yubin🧬 and YunNancyHuang_lab@TAMU 's recent work featured as a cover article with TiPS | cell.com/trends/pharmac… #CancerImmunotherapy #Optogenetics #ImmunoEngineering #TranslationalMedicine

A centuries-old ingredient is being reimagined as a cancer-fighting tool. Early findings show this approach can shrink tumors, improve survival and reduce dangerous side effects in blood cancers like leukemia and lymphoma. Read more at: vitalrecord.tamu.edu/new-research-r… #AggieDocs

A collaborative study with ⁦⁦YunNancyHuang_lab@TAMU⁩ revealing the molecular etiology of tRCC: RNA-mediated condensation of TFE3 oncofusions facilitates transcriptional hub formation to promote translocation renal cell carcinoma - Nature Communications nature.com/articles/s4146…

New in Nature Nanotechnology, we discuss the opportunities of wearable biomolecular sensing technologies in chronic disease management. Cheers to the team! Shana Kelley JiaobingTu Connor Flynn Jeonghee Yeom Caltech Northwestern nature.com/articles/s4156…

Disrupting cancer’s secret hubs: A new way to halt tumor growth vitalrecord.tamu.edu/disrupting-can…

Join us for the 2025 Welch Conference on Chemical Research, “New Horizons in Drug Discovery,” Oct. 27-28 in-person or virtually. The event is completely free! Find more information here: welch1.org/conference/con…

@zhoulaboratory Our latest work on #nanobody #chemogenetics introduces Caffebody and Rapabody — molecular switches controllable by caffeine ☕ or rapamycin 💊 for precise ON/OFF control of protein interactions. | Chemical Science pubs.rsc.org/en/content/art…

Researchers in our Department of Translational Medical Sciences have uncovered how RNA builds “droplet hubs” that fuel one of the toughest childhood cancers—and how to dismantle them. Read more at vitalrecord.tamu.edu/disrupting-can… #CancerResearch #TranslationalMedicine #AdvancingMedicine

The October issue of Cell Press Trends in Pharmacological Sciences is online now. cell.com/trends/pharmac…

A single-component optogenetic toolkit for programmable control of microtubule biorxiv.org/content/10.110…

Uncovering Tumor’s Hidden Networks: A Novel Strategy to Stop Cancer Growth scienmag.com/uncovering-tum…